Interventional Cardiology

-> Abstracts

4/18/2006	Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome Jun-ichi Kotani, Shinsuke Nanto, Gary S. Mintz, Masafumi Kitakaze, Tomoki Ohara, Takakazu Morozumi, Seiki Nagata, Masatsugu Hori
4/18/2006	Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome: A Prospective, Randomized, Controlled Study Gilbert Beran, MD et al
4/18/2006	Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome Jun-ichi Kotani, Shinsuke Nanto, Gary S. Mintz, Masafumi Kitakaze, Tomoki Ohara, Takakazu Morozumi, Seiki Nagata, Masatsugu Hori
4/18/2006	Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial Patrick W. Serruys, et al
4/18/2006	Stroke Complicating Percutaneous Coronary Interventions Incidence, Predictors, and Prognostic Implications Shmuel Fuchs, MD; Eugenio Stabile, MD; Timothy D. Kinnaird, MD; Gary S. Mintz, MD; Luis Gruberg, MD; Daniel A. Canos, MPH; Ellen E. Pinnow, MS; Ran Kornowski, MD; William O. Suddath, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD; Kenneth M. Kent, MD; Neil J. Weissman, MD
4/18/2006	In-stent restenosis in small coronary arteries: Impact of strut thickness Carlo Briguori
4/18/2006	First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome Francesco Liistro, MD et al
4/18/2006	Twelve Versus Six Months of Clopidogrel to Reduce Major Cardiac Events in Patients Undergoing -Radiation Therapy for In-Stent Restenosis Washington Radiation for In-Stent restenosis Trial (WRIST) 12 Versus WRIST PLUS Ron Waksman, MD; Andrew E. Ajani, MD; Ellen Pinnow, MS; Edouard Cheneau, MD; Laurent Leborgne, MD; Regina Dieble, RN; Anh B. Bui, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD; Kenneth K. Kent, MD; Joseph Lindsay, MD
4/14/2006	Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts Waksman R, et al

-> Slide Presentations

5/11/2006	Diabetes and Coronary Artery Disease Robert Frye, MD
5/11/2006	SIRIUS and TAXUS II Lowell Satler
4/19/2006	Lessons from the RAVEL Study Morice
4/19/2006	Clinical and Angiographic Outcomes After Use of Sr-90 Jeffrey J. Popma
4/19/2006	Conflict of Interest and Financial Disclosure Daniel C. Adelman, MD
4/19/2006	TAXOL Program for In-Stent Restenosis Ivan De Scheerder
4/19/2006	An Advanced c-myc Antisense for Prevention of Restenosis Nicholas Kipshidze M.D.
4/19/2006	Research 2002: Who is at Risk, The Patient or Me? Daniel L. Herr M.D.
4/19/2006	Clinical Studies of Jomed Graft Stents Morice
4/19/2006	TAXUS Paclitaxel Eluting Stent Program from Bench to Bedside Mary E. Russell, M.D.
4/19/2006	Major Complications of Complex PCI John S. Douglas Jr. M.D.
4/19/2006	Current State of the PLLA Biodegradable Stent Hideo Tamai, M.D.
4/19/2006	Statin-Mediated Regulation of Vessel Function Kenneth Walsh, Ph.D.
4/18/2006	Why I Am Not a Believer in Drug-Eluting Stents Julio C Palmaz,MD
4/18/2006	PCI and Pharmacologic Therapy for Acute MI and ACS.ppt Peter Berger, MD
4/18/2006	Drug-Eluting Stents: Establishing Standard Methods Robert S. Schwartz, MD
4/18/2006	Heparin Coated Stents David O. Williams, M.D.
4/18/2006	Biocompatibles Phosphorylcholine Coated Stent Program Jeffrey Popma, MD
4/18/2006	The ORBIT Trial Waksman
4/18/2006	Cellular Effects of Intracoronary PhotoPoint PDT Waksman
4/18/2006	An Assesment of Restenosis on the Eve of Drug-Eluting Stents James P. Zidar, M.D.
4/18/2006	What Else Can we Learn From the CABG PTCA Trials? Spencer B. King, III, MD
4/18/2006	PFO Closure Devices Michael C. Slack, MD
4/18/2006	State of the Art Management of Acute MI Gregg W. Stone, MD
4/18/2006	CREDO Peter B. Berger, MD
4/18/2006	Antiplatelet Management for PCI Patients Peter B. Berger, MD
4/18/2006	Which Heparin Should We Use for PCI? Jonathan D. Marmur, MD
4/18/2006	Pharmacology Update: Heparin Is Not Enough Sue Apple, DNSc, RN, CCRN
4/18/2006	Vascular Closure Devices Kelly McNeil-Jones, RN, BSN, RCIS
4/18/2006	Management of SVGs John S. Douglas, Jr., MD
4/18/2006	Laser Angioplasty for Acute MI On Topaz, MD
4/18/2006	Total Occlusion Devices Charles Simonton, MD
4/18/2006	The Use of Ablative Devices in 2003 William O. Suddath, MD
4/18/2006	Devices for PCI Beyond Drug Eluting Stents? Charles Simonton, MD
4/18/2006	Moderate Sedation: Is Your Lab Up-to-Date? Dina L. Rosenthal, RN, BSN, CCRN
4/18/2006	Informed Consent in the Catheterization Lab Daniel L. Herr, MD
4/18/2006	A Brief Look at the History of Interventional Cardiology Kenneth M. Kent, MD
4/18/2006	Controversies in Optimal Antiplatelet Therapy Christopher Cannon, MD
4/18/2006	Diabetes Robert Frye, MD
4/18/2006	Post PCI Management Lowell Satler, MD
4/18/2006	The Future of Interventional Cardiology David R. Holmes, Jr., MD
4/18/2006	Stent Design Matters...All Stents Are Not Created Equal Helmut Schuhlen, MD
4/18/2006	What is the Optimal Antiplatelet Regimen in PCI Patients? Steven R. Steinhubl, MD
4/18/2006	Beyond the Coronary Artery: The Next Generation of Endovascular Therapy Craig Alan Thompson, MD
4/18/2006	Anti-Thrombotic Therapy in PCI James Tcheng, MD
4/18/2006	PFO and Left Atrial Appendage Device Bernhard Meier, MD
4/18/2006	How do all These New Toys Impact Patient Care? Dina L. Rosenthal, RN, BSN, CCRN
4/18/2006	Thoracic Stents Debra L. Dewald, RCIS
4/18/2006	Percutaneous Mitral Valve Repair Kenneth M. Kent, M. D.
4/18/2006	Virtual Histology: Ready for Prime Time? James R. Margolis, MD
4/18/2006	PFO/ ASD Strategies, Treatment Michael C. Slack, MD
4/18/2006	Why and When to Use Low Molecular Weight Heparin Dean Kereiakes, MD
4/18/2006	Alcohol Septal Ablation Kenneth M. Kent, MD
4/18/2006	Virtual Histology: Ready for Prime Time? J.J.R.M. (Hans) Bonnier, MD
4/18/2006	Changes in Strategy: Real World DES Alexandre Abizaid, MD, PhD
4/17/2006	Distal Protection Devices John S. Douglas, MD
4/17/2006	Post Intervention Medical Management Spencer B. King, III, MD
4/17/2006	Thrombectomy Devices Richard E. Kuntz, M.D., M.Sc.
4/17/2006	What's New for SVG? John S. Douglas, Jr., MD
4/17/2006	Chronic Total Occlusion Charles Simonton, MD

-> Coronary Devices

-> Coronary Lesions

6/20/2006	Additional Value of NIR Stent in Treating Long Lesions
6/20/2006	Impact of the Number of Stents on Restenosis
6/20/2006	The Challenge of Ostial In-Stent Restenosis with Intracoronary Radiation Ajani et al.
6/20/2006	Three Strategies for the Treatment of Aorto Ostial Disease: Early and Late Results Abizaid et al.
6/20/2006	Aroto Ostial Disease

-> Patient SubSets

-> Clinical Trials

	ACS & AMI
	Angiomyogenesis & Cell Therapy
	Carotid Interventions

	Imaging
	Complex Coronary Interventions
	Chronic Total Occlusion

	Drug-Eluting Stents
	Emerging Devices & Innovative Therapies
	Nurse & Tech Corner

	Peripheral Interventions
	Vulnerable Plaque
	Workshop with the FDA